Wells Fargo’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Hold
0
– -$143 – 7191
2024
Q1
– Hold
0
– – – 6577
2023
Q4
– Hold
0
– – – 6720
2023
Q3
– Hold
0
– – – 6668
2023
Q2
– Hold
0
– – – 6380
2023
Q1
– Hold
0
– – – 6259
2022
Q4
– Hold
0
– – – 5940
2022
Q3
– Hold
0
– – – 6159
2022
Q2
– Hold
0
– – – 6335
2022
Q1
– Hold
0
– – – 6050
2021
Q4
– Hold
0
– – – 6146
2021
Q3
– Hold
0
– – – 6493
2021
Q2
– Hold
0
– – – 6342
2021
Q1
– Sell
-1
Closed -$586K – 5814
2020
Q4
$516K Hold
1
– – ﹤0.01% 4495
2020
Q3
$620K Hold
1
– – ﹤0.01% 4194
2020
Q2
$1.13M Buy
+1
New +$850K ﹤0.01% 3720
2020
Q1
– Sell
-1
Closed -$479K – 4812
2019
Q4
$160K Hold
1
– – ﹤0.01% 5080
2019
Q3
$199K Buy
+1
New +$365K ﹤0.01% 4965
2019
Q2
– Hold
0
– – – 5395
2019
Q1
– Hold
0
– – – 5052
2018
Q4
– Sell
-5
Closed -$2.6M – 5293
2018
Q3
$3.96M Hold
5
– – ﹤0.01% 2845
2018
Q2
$5.64M Hold
5
– – ﹤0.01% 2571
2018
Q1
$5.75M Buy
5
+1
+25% +$1.14M ﹤0.01% 2517
2017
Q4
$5.3M Buy
4
+2
+100% +$2.81M ﹤0.01% 2531
2017
Q3
$3.75M Buy
+2
New +$3.29M ﹤0.01% 2782

Other funds holding KALA

Wells Fargo's KALA Position: Q2 2024 in Review

Wells Fargo held its KALA BIO (KALA) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7191.

Wells Fargo first reported a position in KALA in Q3 2017 and has held it in 10 quarters since. The position peaked at $5.75M in Q1 2018. 15 funds tracked by Wall St. Rank hold KALA as of Q2 2024.

  • Wells Fargo held 0 shares of KALA BIO worth $0 as of Q2 2024.
  • Wells Fargo left its KALA BIO share count unchanged in Q2 2024.
  • KALA BIO made up ﹤0.01% of Wells Fargo's portfolio in Q2 2024, its #7191 holding.
  • Wells Fargo first reported a position in KALA BIO in Q3 2017 and has held it in 10 quarters since.
  • Wells Fargo's KALA BIO position peaked at $5.75M in Q1 2018.
  • 15 funds tracked by Wall St. Rank held KALA BIO as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.